rs376875223
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6
The NM_001277115.2(DNAH11):c.9907A>G(p.Ile3303Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000428 in 1,610,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. I3303I) has been classified as Benign.
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Publications
- primary ciliary dyskinesia 7Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), ClinGen
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000204 AC: 31AN: 152228Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000653 AC: 16AN: 245040 AF XY: 0.0000452 show subpopulations
GnomAD4 exome AF: 0.0000254 AC: 37AN: 1458462Hom.: 0 Cov.: 30 AF XY: 0.0000234 AC XY: 17AN XY: 725208 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152346Hom.: 0 Cov.: 33 AF XY: 0.000201 AC XY: 15AN XY: 74490 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Uncertain:2Benign:1
- -
- -
The p.I3303V variant (also known as c.9907A>G), located in coding exon 60 of the DNAH11 gene, results from an A to G substitution at nucleotide position 9907. The isoleucine at codon 3303 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at